News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
 Content Sharing
SBP GROUP's Subsidiary Presents Research Data on 2 Self-Developed ADCs at AACR Annual Meeting
SBP GROUP (01177.HK) announced that the latest research data of LM-364 "Nectin-4TME ADC" and LM-338 "STn ADC", two antibody-drug conjugates (ADCs) independently...
Reset
Send
The window will close in 5 seconds
SBP GROUP's Subsidiary Presents Research Data on 2 Self-Developed ADCs at AACR Annual Meeting
Close
Recommend
16
Positive
26
Negative
9
 
SHORT SELL
 
STOCK INFO
aacat by AASTOCKS
Open a new trading account to get NVDA share!

SBP GROUP (01177.HK)  +0.090 (+1.610%)    Short selling $107.45M; Ratio 22.876%   announced that the latest research data of LM-364 "Nectin-4TME ADC" and LM-338 "STn ADC", two antibody-drug conjugates (ADCs) independently developed by LaNova Medicines, its wholly-owned subsidiary, has been presented at the American Association for Cancer Research (AACR) Annual Meeting 2026.

Specifically, LM-364 is a next-generation Nectin-4TME ADC developed by LaNova Medicines leveraging its proprietary tumor microenvironment (TME) platform. This molecule employs an adenine nucleotide (ANP)-dependent binding mechanism: since ANP concentration in the tumor microenvironment (micromolar level) is significantly higher than that in normal tissues (nanomolar level), LM-364 achieves conditionally activated high-affinity binding at tumor sites. This enhances internalization and payload release while significantly reducing off-target toxicity in normal tissues, offering a novel approach to addressing long-standing safety challenges in ADC development.
(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2026-04-24 16:25.)

Related NewsJPM: Profit-taking in China Pharma Sector Presents Good Entry Opportunity

Auto-translated by AI
View Original Text

AASTOCKS Financial News
Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.